Inaktiver Wert

21st North Inc Aktie OTC Bulletin Board

Aktien

Schlusskurs OTC Bulletin Board Andere Börsenplätze
- ^USD	-

2015	Transcript : Urologix, Inc., Q3 2015 Earnings Call, May 12, 2015
2015	Transcript : Urologix, Inc., Q2 2015 Earnings Call, Feb 05, 2015

Transcript : Urologix, Inc., Q3 2015 Earnings Call, May 12, 2015	12.05.15
Transcript : Urologix, Inc., Q2 2015 Earnings Call, Feb 05, 2015	05.02.15
Transcript : Urologix, Inc., Q1 2015 Earnings Call, Nov 04, 2014	04.11.14
Transcript : Urologix, Inc., Q4 2014 Earnings Call, Aug 19, 2014	19.08.14
Transcript : Urologix, Inc., Q3 2014 Earnings Call, May 06, 2014	06.05.14
Transcript : Urologix, Inc., Q2 2014 Earnings Call, Feb 04, 2014	04.02.14
Transcript : Urologix, Inc., Q1 2014 Earnings Call, Oct 29, 2013	29.10.13
Transcript : Urologix, Inc., Q4 2013 Earnings Call, Aug 20, 2013	20.08.13
Transcript : Urologix, Inc., Q3 2013 Earnings Call, May 01, 2013	01.05.13
Transcript : Urologix, Inc., Q2 2013 Earnings Call, Feb 05, 2013	05.02.13
Transcript : Urologix, Inc., Q1 2013 Earnings Call, Nov 14, 2012	14.11.12
Transcript : Urologix, Inc., Q4 2012 Earnings Call, Aug 23, 2012	23.08.12
Transcript : Urologix, Inc., Q3 2012 Earnings Call, Apr 26, 2012	26.04.12

A unknown buyer acquired substantially all of the operating assets of Urologix, Inc.	02.02.16
Urologix Conducting A Strategic Review	09.07.15
Urologix, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2015	12.05.15
Urologix, Inc. Appoints Scott M. Madson as Chief Financial Officer Effective April 1, 2015	23.03.15
Urologix, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2014	05.02.15

Manager	Titel	Alter	Seit
Mitchell Dann FOU	Founder	63	29.05.91
Scott Madson DFI	Director of Finance/CFO	63	01.04.15
Lisa Ackermann SAM	Sales & Marketing	51	16.06.11

Aufsichtsräte	Titel	Alter	Seit
Mitchell Dann FOU	Founder	63	29.05.91
Sidney Emery BRD	Director/Board Member	74	01.10.05
Christopher Barys BRD	Director/Board Member	57	06.08.10

21st North Inc. übt keine operative Tätigkeit aus. Das Unternehmen hat sich aufgelöst.

Sektor

	% 1. Jan.	Kap.
THERMO FISHER SCIENTIFIC	+12.50%	228 Mrd.
DANAHER CORPORATION	+14.52%	196 Mrd.
INTUITIVE SURGICAL, INC.	+17.51%	141 Mrd.
BOSTON SCIENTIFIC CORPORATION	+28.96%	110 Mrd.
SIEMENS HEALTHINEERS AG	+3.27%	65.88 Mrd.
EDWARDS LIFESCIENCES CORPORATION	+18.16%	54.3 Mrd.
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+7.63%	52.39 Mrd.
AGILENT TECHNOLOGIES, INC.	+10.95%	45.22 Mrd.
GE HEALTHCARE TECHNOLOGIES INC.	+5.10%	37.12 Mrd.